Article info

Concise report
Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis

Authors

  1. Correspondence to Dr Shunsuke Mori, Department of Rheumatology, Clinical Research Center for Rheumatic Disease, NHO Kumamoto Saishunsou National Hospital, 2659 Suya, Kohshi, Kumamoto 861-1196, Japan; moris{at}saisyunsou1.hosp.go.jp
View Full Text

Citation

Mori S, Ueki Y, Hirakata N, et al
Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis

Publication history

  • Received July 7, 2012
  • Accepted July 26, 2012
  • First published August 11, 2012.
Online issue publication 
November 02, 2012

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.